Larimar Therapeutics (LRMR)
(Delayed Data from NSDQ)
$6.38 USD
-0.67 (-9.50%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $6.38 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.24 | -4.17% |
Earnings Summary
For their last quarter, Larimar Therapeutics (LRMR) reported earnings of -$0.30 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 20.00%. Look out for LRMR's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year decrease of 60%.
Earnings History
Price & Consensus
Zacks News for LRMR
Larimar (LRMR) Upgraded to Strong Buy: What Does It Mean for the Stock?
LRMR: What are Zacks experts saying now?
Zacks Private Portfolio Services